Science AdvancesMolecular BiologyPeer-reviewed journal article
MeCP2 Interacts with the Super Elongation Complex to Regulate Transcription
Jun Young SonniD, Wonho KimiD, Marta IwanaszkoiD, Yuki AoiiD, Yan LiiD, Guantong Qi, Luke ParkitnyiD, Janice L. BrissetteiD, Lorin WeineriD, Juan BotasiD, Ismael Al‐RamahiiD, Ali ShilatifardiD, Huda Yahya ZoghbiiD
Abstract
Loss-of-function mutations in methyl-CpG binding protein 2 (MECP2) cause Rett syndrome, a postnatal neurodevelopmental disorder that occurs in [~]1/10,000 live female births. MeCP2 binds to methylated cytosines across genomic DNA and recruits various partners to regulate gene expression. MeCP2 has been shown to repress transcription in vitro and interacts with co-repressors such as the Sin3A and NCoR complexes. Based on these observations, MeCP2 has been largely considered as a repressor of transcription. However, a mouse model of RTT displays many down-regulated genes, and those same genes are up-regulated in a MECP2 duplication mouse model. Furthermore, TCF20, which has been associated with transcriptional activation, have recently been identified as a protein interactor of MeCP2. These data broaden the potential functions of MeCP2 as a regulator of gene expression. Yet, the molecular mechanisms underlying MeCP2-dependent gene regulation remain largely unknown. Here, using a human MECP2 gain-of-function Drosophila model, we screened for genetic modifiers of MECP2-induced phenotypes. Our approach identified several subunits of the Drosophila super elongation complex, a P-TEFb containing RNA polymerase II (RNA pol II) elongation factor required for the release of promoter-proximally paused RNA pol II, as genetic interactors of MECP2. We discovered that MeCP2 physically interacts with the SEC in human cells and in the mouse brain. Furthermore, we found that MeCP2 directly binds AFF4, the scaffold of the SEC, via the transcriptional repression domain. Finally, loss of MeCP2 in the mouse cortex caused reduced binding of AFF4 specifically on a subset of genes involved in the regulation of synaptic function, which also displayed the strongest decrease in RNA pol II binding in the genebody. Taken together, our study reveals a previously unrecognized mechanism through which MeCP2 regulates transcription, providing a new dimension to its regulatory role in gene expression.
- organism: mouse
- organism: Drosophila
- research focus: gene regulatory network inference
- research focus: protein structure prediction
- approach: experimental assay
- Citations
- 13
- FWCI
- 6.50
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Human MeCP2 binds to promoters and inhibits transcription in an unmethylated S. cerevisiae genome
LeAnn J. Howe, Joshua A.R. Brown, … Maggie Y.M. Ling·bioRxiv·Aug 12, 2024
- MeCP2 NID interaction with RNA: Implications for Rett Syndrome-Relevant Protein Regulation
Katrina Good, Hilmar Strickfaden, … Juan Ausió·Human Molecular GeneticsPeer-reviewed·Jan 1, 2026
- Methyl-CpG2-binding protein 2 mediates overlapping mechanisms across brain disorders.
Snow Bach, Niamh Ryan, … Daniela Tropea·Scientific ReportsPeer-reviewed·Dec 17, 2020
- LEDGF interacts with the NID of MeCP2 and modulates MeCP2 condensates
Saskia Lesire, Rodrigo Lata, … Zeger Debyser·bioRxiv·Apr 24, 2024
- Neuronal non-CG methylation is an essential target for MeCP2 function
Rebekah Tillotson, Justyna Cholewa-Waclaw, … Adrian Peter Bird·Molecular CellPeer-reviewed·Feb 8, 2021
- Domains of methylated CAC and CG target MeCP2 to tune transcription in the brain
Sabine Lagger, John C. Connelly, … Adrian Peter Bird·PLoS GeneticsPeer-reviewed·May 12, 2017